A new study published in the journal BMJ Innovations that surveyed doctors and nurses in the United Kingdom has found routine breach of patient privacy through the use of digital devices.
A new study published in the journal BMJ Innovations that surveyed doctors and nurses in the United Kingdom has found routine breach of patient privacy through the use of digital devices.
The authors of the study embarked to find out the extent of digital device use among healthcare professionals through a survey conducted among 6000 clinical staff at 5 hospitals in London on ownership and use of portable devices and mobile health apps in the workplace. The results published were the responses of 287 doctors and 564 nurses; nearly all the doctors who participated had a smart phone and nearly 75% owned a tablet. The corresponding numbers for participating nurses were 95% and nearly 65%. While 78% of doctors had downloaded medical apps to their devices, only about 35% of nurses did so.
When queried about their use of SMS, app-based messaging (WhatsApp) and picture messaging using their smartphone’s camera, most said they had done so. Sixty-five percent of doctors said they had used SMS, about 33% had used app-based messaging, and 46% had used picture messaging to share a photo of a patient’s wound or X-ray with a colleague. Nurses, however, reported les frequent use to share such patient data: 14%, 6%, and 7.5%, respectively.
Considering that the information shared on these open networks was not secure, the researchers have urged the NHS to raise awareness among healthcare professionals about the potential risks of sharing patient information using unsecured smartphones.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More